A Sanofi logo sits on the facade of the company's headquarters on December 11, 2020 in Gentilly near Paris, France.
SINGAPORE — French pharmaceutical giant Sanofi on Wednesday opened a 800 million Singapore dollar ($595 million) "evolutive vaccine facility," or EVF, in Singapore — the only such facility the company has outside of France.
The facility will contribute about 200 jobs to the city-state, including bioprocess engineers, automation specialists and data analysts, and will be fully operational by mid-2026.
Sanofi said in a release that the facility holds the potential to significantly bolster pandemic preparedness.
"By establishing the groundwork for crucial production modules now, Modulus can ensure a swift and targeted response to any future health needs, including potential pandemics," the company said.
Persons:
Sanofi
Organizations:
Sanofi, Wednesday, Singapore, Singapore —
Locations:
Gentilly, Paris, France, SINGAPORE, Singapore